Home
>
National Drug Code (NDC)
>
Marqibo
Marqibo - 20536-322-01 - (Vincristine Sulfate)
Drug Information of Marqibo
| Product NDC: | 20536-322 |
| Proprietary Name: | Marqibo |
| Non Proprietary Name: | Vincristine Sulfate |
| Active Ingredient(s): | & nbsp; Vincristine Sulfate |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Marqibo
| Product NDC: | 20536-322 |
| Labeler Name: | Talon Therapeutics, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA202497 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130114 |
Package Information of Marqibo
| Package NDC: | 20536-322-01 |
| Package Description: | 1 KIT in 1 CARTON (20536-322-01) * 1 mL in 1 VIAL, GLASS (20536-324-01) * 25 mL in 1 VIAL, GLASS (20536-325-01) * 5 mL in 1 VIAL, GLASS (20536-323-01) |
NDC Information of Marqibo
| NDC Code | 20536-322-01 |
| Proprietary Name | Marqibo |
| Package Description | 1 KIT in 1 CARTON (20536-322-01) * 1 mL in 1 VIAL, GLASS (20536-324-01) * 25 mL in 1 VIAL, GLASS (20536-325-01) * 5 mL in 1 VIAL, GLASS (20536-323-01) |
| Product NDC | 20536-322 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Vincristine Sulfate |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 20130114 |
| Marketing Category Name | NDA |
| Labeler Name | Talon Therapeutics, Inc |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
